80061090 - Current Topics in Gynecologic Pathology

Saturday, November 4, 2023, 7:00 AM - Sunday, November 5, 2023, 5:30 PM, Online, Baltimore, MD

The Gynecologic Pathology conference is intended as a practical overview for pathologists who encounter gynecologic specimens in daily practice. Interpretations of endometrial, peritoneal, vulvar, and cervical biopsies will be addressed, as well as the approach to ovarian and mesenchymal neoplasms. There will be several slide sessions to accompany the lectures. Participants should gain a better understanding of the interpretation of gynecologic biopsies, ovarian and mesenchymal neoplasms and the application of modern ancillary techniques to gynecologic disorders.

This is an asynchronous, virtual course. Recordings of the lectures will be available up to a week in advance of 11/4, where learners can view at their own pace. There will be a live question and answer session with the speakers on 11/5 via Zoom.

Fees
Physicians and Allied Health Professionals.........  $400
Residents and Fellows............................................  $250

LATE FEE AND REFUND POLICY
A $25 late fee applies to registrations received after 5:00 p.m. ET on October 29, 2023. A handling fee of $25 will be deducted for cancellation. An additional fee may apply for cancellation of other events, including workshops and social activities. Refund requests must be received by fax or mail by October 29, 2023. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins activity in lieu of cancellation is not possible.

1. Describe the prevalence, clinical presentation, genetic basis, and diagnosis of selected genetic syndrome associated gynecologic tumors.
2. Identify the critical immunohistochemical studies used in the analysis of endometrial carcinomas.
3. Describe the diagnostic criteria for fallopian tube serous tubal intraepithelial carcinoma (STIC) and the relationship to high-grade serous carcinoma.
4. Describe the clinicopathologic features of sex cord-stromal ovarian neoplasms.
5. Recognize the clinicopathologic features of vulvar inflammatory lesions.
6. Discuss the concept and definition of mesonephric adenocarcinoma (MA) and mesonephric-like adenocarcinoma (MLA).
7. Describe the molecular classification of endometrial cancer defined in the WHO classification of Tumors, 5th Ed., Female Genital Tumors.
8. Describe the diagnostic criteria for cervical squamous intraepithelial lesions.
9. Describe the immunohistochemical stains used in the analysis of peritoneal biopsies.
10. Review the classification of gestational trophoblastic disease and the differential diagnosis of hydatidiform moles.
11. Illustrate the use of ancillary techniques to refine diagnosis of gestational trophoblastic disease: a. *p57 immunohistochemistry b. *Molecular genotyping
12. Demonstrate the Relationship of synchronous and metachronous mucinous tumors involving the ovary and another organ (Adventures in Masquerading) a. *Pseudomyxoma peritonei (PMP) b. *Metastatic mucinous carcinomas (deceptive forms)
13. Describe and illustrate diagnostic criteria of ovarian mucinous tumors.
14. Describe the essential and desirable diagnostic criteria of mesonephric adenocarcinoma and mesonephric-like adenocarcinoma.
15. Describe the diagnostic criteria for uterine mesenchymal neoplasms.

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SYLLABUS AND LOG IN INFORMATION
The syllabus and zoom webinar link will be accessible online and via your mobile device in the CloudCME App one week prior to the activity start date. To access, please visit our website. CME Website: https://hopkinscme.cloud-cme.com
(Sign In, Click My CME tab, Click Syllabus)

An outcome survey will be sent to all physician attendees within two months post activity to assist us in determining what impact this activity had on the learner’s practice.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

HOW TO OBTAIN CREDIT
Post activity, an online evaluation will be available to attendees to evaluate the activity and individual presentations and to identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. Credits earned will be added to the learner’s transcript and immediately available for print. The last day to access the evaluation and attest to your credits is December 20, 2023.

AMERICANS WITH DISABILITIES ACT
The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.